Isomorphic, which formed as an Alphabet company in 2021, has a massive cash horde, but it’s tight-lipped on what drugs it ...

The proceeds will be used to accelerate Isomorphic Labs’ pipeline of therapeutic programmes and further develop its IsoDDE AI drug design engine.

May 12 (Reuters) - Isomorphic Labs, an artificial intelligence-driven drug discovery company, said on Wednesday it has raised ...

If any proof was needed that big money is still available for AI drug development, look no further than the ten-figure series B hauled in by Isomorphic Labs. The London-based AI drug discovery firm ...

Sir Demis Hassabis has hailed a multi-billion-dollar investment in the startup he founded which was spun out of Google ...

Alphabet-backed start-up Isomorphic Labs has added to the lustre attached to its AI-powered drug discovery engine by raising ...

Isomorphic Labs secures $2.1 billion in funding to accelerate its AI-powered drug discovery engine and scale pharmaceutical ...

Isomorphic Labs secured $2.1 billion in a Thrive Capital-led round to scale its AI-driven drug discovery platform, with ...

The round, completed at an undisclosed valuation, included participation from existing backers Google Ventures and Alphabet, ...

Isomorphic Labs will use the funding to power its world-leading AI drug design engine, scale its business globally and progress its drug candidate pipeline. LONDON, May 12, 2026 /CNW/ -- Isomorphic ...

In 2024, DeepMind and Isomorphic Labs released a significantly improved successor to the model. AlphaFold 3 delivers a more ...

Isomorphic Labs raised $2.1 billion in its Series B funding round to boost its artificial-intelligence drug design pipeline across multiple therapeutic areas. The subsidiary of Google parent Alphabet ...